Target intelligence / Profile preview

Ribosomal protein L24 pseudogene 5 (RPL24P5)

Target: RPL24P5
Molecular classification: Other (Pseudogene; non-coding genomic locus)

Overview

Ribosomal protein L24 pseudogene 5 (RPL24P5) is a genomic region in humans classified as a pseudogene related to the ribosomal protein L24. Unlike its protein-coding counterpart RPL24, RPL24P5 does not produce a functional protein and does not participate in cellular processes such as ribosome assembly or protein synthesis. Pseudogenes like RPL24P5 are typically remnants of evolutionary gene duplication or retrotransposition events and serve as markers of genome architecture but do not have direct biological or therapeutic significance[7].

Other names: RPL24_1_143RPL24P5Ribosomal protein L24 pseudogene 5

Mechanism of action

None. Drug mechanisms are not applicable due to the absence of a functional gene product

Biological functions

None. As a pseudogene, it does not have an active biological role or contribute to protein synthesis or cellular pathways

Disease associations

None established. There is no evidence linking RPL24P5 to any disease phenotype or pathogenesis

Safety considerations

None. There are no therapeutic challenges or safety concerns associated with targeting a pseudogene, as it is not a functional target

Interacting drugs

None. No drugs are known to interact with or target this pseudogene

Biomarkers

None. It is not used as a biomarker for patient selection or monitoring

Beyond the preview

Go deeper on Ribosomal protein L24 pseudogene 5 (RPL24P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L24 pseudogene 5 (RPL24P5).

Explore the full profile